Immune Checkpoint Inhibitor Toxicity (I-CHECKIT): A Prospective Observational Study
Eligible for screening study DCP 001
Pre Registration QOLs- To be completed after consent, prior to registration.
S2013, Cohort 2 is open to accrual & Cohort 1 is closed to accrual effective November 19, 2024 with the implementation of Revision 6